2,230.63
81,685.1
2.81%
46.6
1,424.35
3.38%
58.8
1,948
3.11%
92.25
3,534.45
2.68%
23.25
1,871.5
1.26%
43.35
1,432.05
3.12%
16.15
795.55
2.07%
60.25
1,567.7
4%
50.85
2,384.8
2.18%
307.4
8,947.6
3.56%
10.65
434.15
2.51%
22.4
809.2
2.85%
89.3
3,535
2.59%
54.45
1,624.35
3.47%
-60.5
1,684.35
-3.47%
51.25
2,155
2.44%
252.65
12,505
2.06%
78.35
3,061.1
2.63%
42.45
1,195.8
3.68%
232.4
11,606
2.04%
10.75
345.35
3.21%
63.15
2,033.45
3.21%
43.95
3,554.75
1.25%
-14.9
4,486
-0.33%
6.6
241.35
2.81%
49.55
1,356.65
3.79%
8.95
308.5
2.99%
10.5
719
1.48%
138.35
2,390.1
6.14%
44.95
4,018.25
1.13%
9
250.9
3.72%
10.1
392.75
2.64%
25.75
982.6
2.69%
2.55
318.3
0.81%
44.15
2,367.95
1.9%
61.65
2,362
2.68%
8.05
235
3.55%
236.6
7,920.1
3.08%
32.05
545.55
6.24%
3
142.95
2.14%
349.6
5,449.65
6.85%
210
5,324.15
4.11%
89.7
2,723.3
3.41%
4.6
147.35
3.22%
17.5
425.6
4.29%
46.95
1,746.05
2.76%
14.55
510.85
2.93%
17.65
425.5
4.33%
-75.75
5,925.35
-1.26%
12.4
260.5
5%
36.45
667.95
5.77%
2230.63
81685.1
2.81%
Home|MytestPage_shyamal

CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Pharmaceutical Sector and China One Plus Story
Ninad Ramdasi
/ Categories: DSIJ_Magazine_Web, Letter to Editor, DSIJMagazine_App, Editorial, Letter to Editor

Pharmaceutical Sector and China One Plus Story

Your cover story in the previous issue meticulously explained the sectors that stand to benefit from the emerging China Plus One story. Can you shed some light on whether the domestic pharmaceutical sector will also gain from this strategy? - Ayansh K 

Previous Article This Diwali Let the Lights Shine Brighter!
Next Article Sectoral Funds have Caught Investors Attention this Diwali!
Print
106 Rate this article:
5.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered and Correspondence Office Address :
DSIJ PVT LTD. Office No - 409,
Solitaire Business Hub, Kalyani Nagar, Pune - 411006
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList
Menu
For Investor
For Trader
Advisory Service
Insight
Markets
More